BCRX — BIOCRYST PHARMACEUTICALS INC

Ownership history in Quantbot Technologies LP  ·  14 quarters on record

This page tracks every 13F SEC filing in which Quantbot Technologies LP reported a position in BIOCRYST PHARMACEUTICALS INC (BCRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2021 Q3)
Avg. % of fund
0.01%
First filed
2014 Q1
Last filed
2025 Q3
Quarters held
14
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 14,844 -21,308 -58.9% 0.00% $113K $7.59
2025 Q2 ADDED 36,152 +35,781 +9644.5% 0.01% $324K $8.96
2024 Q3 REDUCED 371 -21,929 -98.3% 0.00% $3K $7.60
2024 Q1 ADDED 22,300 +19,900 +829.2% 0.01% $113K $5.08
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    BCRX price (monthly, adj. close)

Other funds also holding BCRX

As of 2025 Q4 — sorted by position size

Elmind Capital, LP 4.95% Kynam Capital Management, LP 3Y 4.67% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.43% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.26% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 1.26% Eversept Partners, LP 3Y 7Y 1.18% RICE HALL JAMES & ASSOCIATES, LLC 3Y 7Y 0.82% DAFNA Capital Management LLC 3Y 7Y 0.76% Parkman Healthcare Partners LLC 3Y 0.67% Vestal Point Capital, LP 0.6%
← Back to Quantbot Technologies LP Holdings